{"nct_id":"NCT05952557","title":"An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2023-10-05","start_date_type":"ACTUAL","primary_completion_date":"2030-03-04","primary_completion_date_type":"ESTIMATED","completion_date":"2037-05-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}